Landos Biopharma Inc (NAS:LABP)
$ 22.93 0 (0%) Market Cap: 71.68 Mil Enterprise Value: 42.67 Mil PE Ratio: 0 PB Ratio: 3.09 GF Score: 36/100

Landos Biopharma Inc Annual Shareholders Meeting Transcript

May 23, 2023 / 01:00PM GMT
Release Date Price: $3.29 (+8.55%)
Operator

Good day, and welcome to the Landos Biopharma 2023 Annual Meeting of Stockholders. I would now like to turn the conference over to Gregory Oakes, President and Chief Executive Officer. Please go ahead.

Gregory Oakes
Landos Biopharma, Inc. - President & CEO

Thanks, Priscilla. Good morning. I'm Gregory Oakes, and I'm the President and Chief Executive Officer of Landos Biopharma, Inc. I'm very happy to welcome you to the Landos 2023 stockholders' meeting.

Before I call the meeting to order, I'd like to introduce you to members of the Board and business team who are with us today. The other members of the Board here today are Chris Garabedian, Fred Callori, Tiago Girão, Roger Adsett, and Tim Mayleben. Our officers here today are Fabio Cataldi, our Executive Vice President and Chief Medical Officer and Patrick Truesdell, our Vice President and Controller.

I would also like to introduce Meredith Friga of Ernst & Young LLP, our independent registered public accounting firm for our available to respond to appropriate questions. Finally, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot